PLANT-BASED SYNERGISTIC THERAPY OF PTEROCARPUS SANTALINOIDES AND TETRAPLEURA TETRAPTERA EXTRACTS AGAINST STREPTOCOCCUS PNEUMONIAE

Authors

  • CHRISTIAN CHUKWUEMEKA IKE Department of Microbiology, University of Agriculture and Environmental Sciences (UAES), Umuagwo, Imo State, Nigeria https://orcid.org/0000-0002-0036-5638
  • VIVIAN CHIKA IGIRI Department of Microbiology, University of Agriculture and Environmental Sciences (UAES), Umuagwo, Imo State, Nigeria
  • PATRICIA UDOKA NNADI Department of Microbiology, Kingsley Ozumba Mbadiwe University Ogboko, Ideato, Imo State, Nigeria

DOI:

https://doi.org/10.22159/ijcpr.2025v17i4.7032

Keywords:

Antimicrobial synergy, Phytochemicals, Traditional medicine, Health risk

Abstract

Objective: This study investigated the plant-based synergistic therapy of Pterocarpus santalinoides and Tetrapleura tetraptera against Streptococcus pneumoniae.

Methods: Qualitative phytochemical screening of bioactive extracts of both plants, and the sensitivity test against Streptococcus pneumoniae were conducted.

Results: Screening results revealed the presence of alkaloids, tannins, glycosides, saponins, flavonoids, and sterols in the extracts, with sterols absent in T. tetraptera. Sensitivity results showed that the minimum inhibitory concentrations (MICs) for P. santalinoides, T. tetraptera, and their combination were 25 mg/ml, 50 mg/ml, and 6.25 mg/ml, respectively.

Conclusion: The superior efficacy of the combined extract underscores the potential of phytochemical synergy in developing effective, low-cost therapeutic alternatives to synthetic antibiotics, particularly for use in rural settings with limited healthcare access. It has also highlighted the promise of such a combination as an efficacious phytomedicine to combat S. pneumoniae infections, by potentially reducing treatment time, increasing cure rates, and decreasing drug resistance.

Downloads

Download data is not yet available.

References

1. World Health Organization (WHO). Resolution promotion and development of training and research in traditional medicine: WHO document; 2013. p. 47-9.

2. Nwokorie CC, Nwachukwu NC, Ezeanokete CC, Ike CC. The phytochemical and antimicrobial analysis of pterocarpus santalinoides plants. Asian J Sci Technol (AJST). 2015;6(5):1411-8.

3. Ekeke BC, Okwu DE. Phytochemical screening and the medical composition of chewing stick in south eastern Nigeria. Glob J Pure Appl Sci. 2009;9(2):235-8. doi: 10.4314/gjpas.v9i2.15962.

4. Igoli J, Ogaji O, Tor Anyiin T, Igoli N. Traditional medicine practice amongst the igede people of Nigeria part ii. Afr J Trad Compl Alt Med. 2005;2(2):134-52. doi: 10.4314/ajtcam.v2i2.31112.

5. Alexis V, Michele M. Anti-plasmodial activity of plant extract used in West African medicine. J Ethnogr Pharmacol. 2000;73(1-2):141-51.

6. Ike CC, Nnadi PU, Onyenama AC, Emeka Ike PC, Ogwuegbu HO, Igiri VC. Bioactive potential and safety of Tetrapleura tetraptera against bacterial pathogens of cucumber fruits. Unpublished work; 2025.

7. Kigigha LT, Izah SC, Ehizibue M. Activities of Aframomummelegueta seed against Escherichia coli S. aureus and Bacillus species. Point J Bot Microbiol Res. 2015;1:23-9.

8. Enaregha EB, Izah SC, Okiriya Q. Antibacterial properties of Tetrapleura tetraptera pod against some pathogens. Res Rev Insights. 2021;5:1-4.

9. Achi OK. Composition and antibacterial activities of Tetrapleura tetraptera Taub Pod extracts. J Microbiol. 2006;1(5):416-22.

10. Chang Hui S. Molecular diagnosis of infectious diseases: diagnostic molecular biology. 2nd ed. Academic Press; 2023. p. 457-90.

11. Edeoga HO, Okwu DE, Mbaebie BO. Phytochemical constituents of some Nigerian medicinal plants. Afr J Biotechnol. 2005;4(7):685-8. doi: 10.5897/AJB2005.000-3127.

12. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 30th ed. CLSI supplement M100. West Valley Road: Clinical and Laboratory Standards Institute, Wayne Pennsyvania, USA; 2020. p. 1-332.

13. American Society for Microbiology (ASM). Kirby-Bauer disk diffusion susceptibility test protocol. In: Hudzicki J, editor. American Society for Microbiology Washington DC, USA 2016; 2009. p. 1-23.

14. Korang J, Owusu Asante JO, Ibrahim S, Ofori E, Owusu J. Phytochemicals and biological activities of Tetrapleura tetraptera seed extracts. Ghana J Sci. 2023;64(1):34-40. doi: 10.4314/gjs.v64i1.4.

15. OjoOO, Ayayi SS, Owolabi LO. Phy¬tochemical screening, anti-nutrient composi¬tion, proximate analyses and the antimicrobial activities of the aquesous and organic extracts of bark of Rauvolfia vomitoria and leaves of Peperomiapellucida. Int Res J BiochemBioinfo. 2012; 296:127-134.

16. Kundu A, Dey P, Sarkar P, Karmakar S, Tae IH, Kim KS. Protective effects of croton hookeri on streptozotocin-induced diabetic nephropathy. Food Chem Toxicol. 2020 Jan;135:110873. doi: 10.1016/j.fct.2019.110873, PMID 31600566.

17. Das A, Pandita D, Jain GK, Agarwal P, Grewal AS, Khar RK. Role of phytoconstituents in the management of COVID-19. Chem Biol Interact. 2021 May 25;341:109449. doi: 10.1016/j.cbi.2021.109449, PMID 33798507.

18. Dong S, Yang X, Zhao L, Zhang F, Hou Z, Xue P. Antibacterial activity and mechanism of action saponins from Chenopodium quinoa willd husks against foodborne pathogenic bacteria. Ind Crops Prod. 2020;149:112350. doi: 10.1016/j.indcrop.2020.112350.

19. Panche AN, Diwan AD, Chandra SR. Flavonoids: an overview. J Nutr Sci. 2016;5:e47. doi: 10.1017/jns.2016.41, PMID 28620474.

20. Jain T, Bathla S. Plant sterols for human health a review. J Appl Nat Sci. 2015;7(2):1081-7. doi: 10.31018/jans.v7i2.734.

21. Izebe SK, Ibrahim YK, Onoalapo JA, Ibrahim K, Oladosu P, Ibekwe NN. Synergistic activity of Tetrapleura tetraptera and Abrus precatorius fractions extract against Streptococcus pneumoniae and mycobacterium tuberculosis. J Phytomed Ther. 2023;22(1):1045-57. doi: 10.4314/jopat.v22i1.3.

Published

15-07-2025

How to Cite

IKE, CHRISTIAN CHUKWUEMEKA, et al. “PLANT-BASED SYNERGISTIC THERAPY OF PTEROCARPUS SANTALINOIDES AND TETRAPLEURA TETRAPTERA EXTRACTS AGAINST STREPTOCOCCUS PNEUMONIAE”. International Journal of Current Pharmaceutical Research, vol. 17, no. 4, July 2025, pp. 109-12, doi:10.22159/ijcpr.2025v17i4.7032.

Issue

Section

Original Article(s)